Tag: allogeneic cell therapy market data

  • Comprehensive Allogeneic Cell Therapy Market Analysis 2024: Size, Share, And Key Trends

    Comprehensive Allogeneic Cell Therapy Market Analysis 2024: Size, Share, And Key Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Allogeneic Cell Therapy Market from 2024 to 2033?
    The allogenic cell therapy market has grown rapidly, projected to rise from $0.97 billion in 2023 to $1.08 billion in 2024, at a CAGR of 11.3%. Growth is attributed to a focus on donor cell selection and genetic modifications, a rising population, the burden of chronic diseases, and increased collaboration for biosimilar development.

    The allogenic cell therapy market is projected to grow rapidly, reaching $1.67 billion by 2028, with a CAGR of 11.6%. This growth is attributed to the demand for advanced medical treatments, the rise in clinical trials, and increased patient populations. Key trends include technological advancements, partnerships, collaborations, and new product launches.

    Claim Your Free Sample of the Global Allogeneic Cell Therapy Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=15976&type=smp

    What Key Factors Are Fueling the Growth of the Allogeneic Cell Therapy Market?
    The increasing prevalence of chronic diseases is expected to drive growth in the allogeneic cell therapy market. Chronic diseases require ongoing medical care and can diminish quality of life. The rise in chronic illnesses is linked to lifestyle changes, genetics, and environmental factors. Allogeneic cell therapy offers potential treatments by using healthy donor cells to repair dysfunctional tissues. For instance, the National Center for Biotechnology Information projected a 99.5% increase in the number of people aged 50 and older with chronic illnesses by 2050. Therefore, the rise in chronic diseases is propelling the allogeneic cell therapy market.

    What Are the Major Segments of the Allogeneic Cell Therapy Market?
    1) By Type: Stem Cell Therapies, Non-Stem Cell Therapies
    2) By Therapeutic Area: Hematological Disorders, Dermatological Disorders, Other Therapeutic Area
    3) By End User: Hospitals, Specialty Clinics, Research Organizations

    What New Trends Are Transforming the Allogeneic Cell Therapy Market?
    Major companies in the allogeneic cell therapy market are developing innovative cell processing platforms to enhance their market position. In March 2024, Getinge, a Sweden-based healthcare company, launched Livit ACE in partnership with UK-based CellRev, offering a continuous cell processing platform with advanced automation and bioprocessing capabilities.

    Order Now for Fast Delivery of Your Allogeneic Cell Therapy Market Report!
    https://www.thebusinessresearchcompany.com/report/allogeneic-cell-therapy-global-market-report

    Which Regions Are Driving Growth in the Allogeneic Cell Therapy Market?
    North America was the largest region in the allogeneic cell therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allogeneic cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Allogeneic Cell Therapy Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the allogeneic cell therapy market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Allogeneic Cell Therapy Market Include

    1. Allogeneic Cell Therapy Market Executive Summary
    2. Allogeneic Cell Therapy Market Segments
    3. Allogeneic Cell Therapy Market Size And Template Market Growth Rate
    4.  Key Allogeneic Cell Therapy Market Trends
    5. Major Allogeneic Cell Therapy Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Allogeneic Cell Therapy Market
    26. Top Allogeneic Cell Therapy Companies
    27. Allogeneic Cell Therapy Market Opportunities And Strategies
    28. Allogeneic Cell Therapy Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Audio Communication Monitoring Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/audio-communication-monitoring-global-market-report

    Digital Audio Workstation Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/digital-audio-workstation-global-market-report

    Home Audio Equipment Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/home-audio-equipment-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Growth Trajectory Of The Allogeneic Cell Therapy Market 2024-2033

    Growth Trajectory Of The Allogeneic Cell Therapy Market 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    The allogeneic cell therapy market is experiencing rapid growth, driven by increased demand for advanced medical treatments and technological innovations. Here’s an overview of the current market trends, major players, and future outlook.

    Market Overview and Growth

    • Current Market Size: The allogeneic cell therapy market was valued at $0.97 billion in 2023.
    • Short-Term Forecast: Expected to grow to $1.08 billion in 2024, with a compound annual growth rate (CAGR) of 11.3%.
    • Long-Term Forecast: Projected to reach $1.67 billion by 2028, driven by a CAGR of 11.6%.

    Drivers of Growth:

    • Increased Demand: Rising need for advanced treatments and novel therapies.
    • Clinical Trials: Growing number of clinical trials and increasing patient populations.
    • Income Levels: Higher income levels contribute to greater healthcare expenditure.

    Factors Influencing Growth

    • Tailored Treatments: Enhanced focus on personalized donor cell selection and genetic modifications.
    • Population Growth: Increasing global population and burden of chronic diseases.
    • Collaborations: Growing number of collaborations for biosimilar development and novel therapies.

    View More On The Allogeneic Cell Therapy Market Report 2024 – https://www.thebusinessresearchcompany.com/report/allogeneic-cell-therapy-global-market-report

    Impact of Chronic Diseases

    • Prevalence: Chronic diseases are on the rise due to lifestyle changes, environmental factors, and genetic predispositions.
    • Therapeutic Potential: Allogeneic cell therapy offers significant promise for treating chronic illnesses by repairing or replacing dysfunctional cells with healthy donor cells.
    • Future Projections: By 2050, the number of people over 50 suffering from chronic illnesses in the US is expected to nearly double, reaching 142.66 million.

    Major Players and Innovations

    Key Companies:

    • Novartis AG
    • Bristol Myers Squibb Company
    • Takeda Pharmaceutical Company Limited
    • Bluebird Bio Inc.
    • Poseida Therapeutics Inc.
    • Fate Therapeutics Inc.
    • Fortress Biotech Inc.
    • Sorrento Therapeutics Inc.
    • Eureka Therapeutics Inc.
    • Juno Therapeutics Inc.

    Recent Developments:

    • Innovative Platforms: Companies are developing advanced cell processing platforms. For instance, Getinge’s partnership with CellRev led to the launch of Livit ACE, a cutting-edge platform for continuous cell processing. This platform features advanced automation and bioprocessing technologies that improve efficiency and scalability in cell production.
    • Strategic Acquisitions: In November 2021, Takeda acquired GammaDelta Therapeutics to enhance its cell therapy and immuno-oncology capabilities, focusing on gamma-delta T cell therapies.

    Market Segmentation

    • By Type:
      • Stem Cell Therapies
      • Non-Stem Cell Therapies
    • By Therapeutic Area:
      • Hematological Disorders
      • Dermatological Disorders
      • Other Therapeutic Areas
    • By End User:
      • Hospitals
      • Specialty Clinics
      • Research Organizations

    Regional Insights

    • North America: Largest market in 2023 due to advanced healthcare infrastructure and high adoption rates.
    • Asia-Pacific: Expected to be the fastest-growing region in the forecast period, driven by increasing healthcare investments and expanding patient populations.

    Conclusion

    The allogeneic cell therapy market is poised for significant growth, fueled by advancements in technology, rising chronic disease prevalence, and increased demand for innovative treatments. With major companies investing in new platforms and strategic acquisitions, the market is set to expand rapidly, offering promising opportunities for both existing players and new entrants.

    Request A Sample Of The Global Allogeneic Cell Therapy Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15976&type=smp